Smartwatches have been advancing rapidly in terms of features offered — from fitness and lifestyle features to now medical features. Continuing the same, Withings has announced its new product named Withings ScanWatch at Consumer Electronics Show 2020.
The company claims that it is the first hybrid to offer medical-grade Electrocardiogram and sleep apnea detection. The device comes with a larger display than any of the company’s previous models.
It also comes with a redesigned crown and is powered by a battery that is claimed to offer 30-day usage on a single charge. As for the highlighting feature, similar to the Apple Watch, this new Withings ScanWatch looks for early signs of AFib. When the user is experiencing symptoms, or the watch is alerting an irregular heartbeat, an ECG can be taken within 30 seconds.
There’s an SpO2 sensor that emits and absorbs a light wave passing through blood vessels which can help the watch detect sleep apnea. It measures oxygen saturation within the blood, centralizing all the info in the Health Mate app, together with sleep monitoring data for length, depth, and quality.
Users can also track activity and workout through Health Mate which is also capable of sharing data with more than 100 third-party apps such as Apple Health, Google
The Withings ScanWatch will be available in two sizes — 38mm and 42mm. It will go on sale starting Q2 2020 in Europe and the U.S. for €249/£229/$249 (38mm), and €299/£279/$299 (42mm), after it gets CE and FDA-clearance.